JP2022527025A5 - - Google Patents
Info
- Publication number
- JP2022527025A5 JP2022527025A5 JP2021560413A JP2021560413A JP2022527025A5 JP 2022527025 A5 JP2022527025 A5 JP 2022527025A5 JP 2021560413 A JP2021560413 A JP 2021560413A JP 2021560413 A JP2021560413 A JP 2021560413A JP 2022527025 A5 JP2022527025 A5 JP 2022527025A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- administration
- compound according
- formula
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962828995P | 2019-04-03 | 2019-04-03 | |
| US62/828,995 | 2019-04-03 | ||
| US201962879794P | 2019-07-29 | 2019-07-29 | |
| US62/879,794 | 2019-07-29 | ||
| US201962933632P | 2019-11-11 | 2019-11-11 | |
| US62/933,632 | 2019-11-11 | ||
| PCT/US2020/026732 WO2020206363A1 (en) | 2019-04-03 | 2020-04-03 | Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527025A JP2022527025A (ja) | 2022-05-27 |
| JP2022527025A5 true JP2022527025A5 (https=) | 2023-04-17 |
Family
ID=72666280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560413A Pending JP2022527025A (ja) | 2019-04-03 | 2020-04-03 | 神経変性疾患及びミトコンドリア病の治療のための組成物及びその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220162215A1 (https=) |
| EP (1) | EP3947390A4 (https=) |
| JP (1) | JP2022527025A (https=) |
| KR (1) | KR20220004068A (https=) |
| CN (1) | CN114026093A (https=) |
| AU (1) | AU2020253561A1 (https=) |
| BR (1) | BR112021019802A2 (https=) |
| CA (1) | CA3135755A1 (https=) |
| IL (1) | IL286767A (https=) |
| MX (1) | MX2021012129A (https=) |
| WO (1) | WO2020206363A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018290225A1 (en) | 2017-06-21 | 2020-01-23 | Mitokinin, Inc. | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease |
| US20250129080A1 (en) * | 2021-08-20 | 2025-04-24 | Mitokinin, Inc. | Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease |
| WO2023023671A1 (en) * | 2021-08-20 | 2023-02-23 | Mitokinin, Inc. | Compositions and methods for treatment of neurodegenerative and mitochondrial disease |
| WO2024040266A2 (en) * | 2022-08-19 | 2024-02-22 | Mitokinin, Inc. | Disubstituted benzoimidazole and indole analogs as modulators of pink1 |
| EP4620957A1 (en) * | 2024-03-22 | 2025-09-24 | Eberhard Karls Universität Tübingen | Imidazo[4,5-b]pyridin-7-amine compounds binding aurora kinase a and uses thereof |
| CN118290348A (zh) * | 2024-03-22 | 2024-07-05 | 诚达药业股份有限公司 | 一种4-氯吡咯并嘧啶类化合物或其衍生物的合成方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9613021D0 (en) * | 1996-06-21 | 1996-08-28 | Pharmacia Spa | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| CN101282761A (zh) * | 2005-08-04 | 2008-10-08 | 西特里斯药业公司 | 作为sirtuin调节剂的苯并咪唑衍生物 |
| ES2412384T3 (es) * | 2006-07-18 | 2013-07-11 | Astellas Pharma Inc. | Derivado de aminoindano o sal del mismo |
| WO2014124458A1 (en) * | 2013-02-11 | 2014-08-14 | The Regents Of The University Of California | Compositions and methods for treating neurodegenerative diseases |
| EP2818472A1 (en) * | 2013-06-27 | 2014-12-31 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators |
| ES2919024T3 (es) * | 2014-02-11 | 2022-07-21 | Mitokinin Inc | Composiciones y procedimientos que utilizan las mismas para el tratamiento de enfermedades neurodegenerativas y mitocondriales |
| JP2018537502A (ja) * | 2015-12-16 | 2018-12-20 | サウザーン リサーチ インスチチュート | ピロロピリミジン化合物、キナーゼｌｒｒｋ２阻害剤としての使用、及びその調製方法 |
| WO2018065365A1 (en) * | 2016-10-03 | 2018-04-12 | Janssen Pharmaceutica Nv | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors |
| WO2018106818A1 (en) * | 2016-12-07 | 2018-06-14 | Kura Oncology, Inc. | Methods of promoting beta cell proliferation |
| AU2018290225A1 (en) * | 2017-06-21 | 2020-01-23 | Mitokinin, Inc. | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease |
| CN115515682B (zh) * | 2020-02-21 | 2024-06-21 | 麦托吉宁公司 | 用于治疗神经退行性疾病和线粒体疾病的组合物及其使用方法 |
-
2020
- 2020-04-03 AU AU2020253561A patent/AU2020253561A1/en not_active Abandoned
- 2020-04-03 CN CN202080040787.8A patent/CN114026093A/zh active Pending
- 2020-04-03 BR BR112021019802A patent/BR112021019802A2/pt not_active Application Discontinuation
- 2020-04-03 KR KR1020217035783A patent/KR20220004068A/ko not_active Withdrawn
- 2020-04-03 MX MX2021012129A patent/MX2021012129A/es unknown
- 2020-04-03 CA CA3135755A patent/CA3135755A1/en active Pending
- 2020-04-03 EP EP20784272.5A patent/EP3947390A4/en not_active Withdrawn
- 2020-04-03 US US17/601,372 patent/US20220162215A1/en not_active Abandoned
- 2020-04-03 WO PCT/US2020/026732 patent/WO2020206363A1/en not_active Ceased
- 2020-04-03 JP JP2021560413A patent/JP2022527025A/ja active Pending
-
2021
- 2021-09-29 IL IL286767A patent/IL286767A/en unknown
-
2025
- 2025-03-24 US US19/088,609 patent/US20250250276A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527025A5 (https=) | ||
| JP2024543982A5 (https=) | ||
| JP2021534106A5 (https=) | ||
| RU2007116119A (ru) | Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с | |
| JP2021534108A5 (https=) | ||
| JP2008514732A5 (https=) | ||
| JP2016506387A5 (https=) | ||
| KR930019213A (ko) | 간염치료에 유용한 1,3-옥사티올란류 | |
| RU2012110380A (ru) | Новое производное 5-фторурацила | |
| RU2005107314A (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью | |
| JP2009526831A5 (https=) | ||
| JP2008526999A5 (https=) | ||
| MX2008010187A (es) | Tratamiento de distrofia muscular de duchenne. | |
| HUP0001446A2 (hu) | HIV reverz transzkriptáz inhibitor hatású 4,4-diszubsztituált-3,4-dihidro-2(1H)-kinazolinon-származékok, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
| CA2481482A1 (en) | Tropane derivatives as ccr5 modulators | |
| JP2002537292A5 (https=) | ||
| KR927003586A (ko) | 신규한 중추 작용성 6,7,8,9-테트라하이드로-3H-벤즈(e)인돌 헤테로사이클 화합물 | |
| RU2004134719A (ru) | Производные n-ацилпиперидина для применения в качестве лигандов мелатокортиновых рецепторов при лечении пищевых нарушений | |
| RU2001107139A (ru) | Мускариновые агонисты и антагонисты | |
| JP2022552159A5 (https=) | ||
| CA2434028A1 (en) | Amino ceramide-like compounds and therapeutic methods of use | |
| JP2006508965A5 (https=) | ||
| JP2005525398A5 (https=) | ||
| RU2002101622A (ru) | Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом | |
| JP2005513017A5 (https=) |